Current and emerging treatments for relapsing multiple sclerosis in Argentinian patients: a review

被引：1
|
作者：
Rojas, Juan I. [1 ]
Patrucco, Liliana [1 ]
Cristiano, Edgardo [1 ]
机构：
[1] Hosp Italiano Buenos Aires, Neurol Dept, Multiple Sclerosis Ctr Buenos Aires, Buenos Aires, DF, Argentina
来源：
DEGENERATIVE NEUROLOGICAL AND NEUROMUSCULAR DISEASE | 2014年 / 4卷
关键词：
multiple sclerosis; Argentina; treatments; disease-modifying drugs;
D O I：
10.2147/DNND.S46557
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Multiple sclerosis (MS) is an autoimmune disease of the central nervous system. Recent developments have led to newer therapeutic options for disease treatment. A few studies have reported MS prevalence rates between 12 and 20 per 100,000 inhabitants nationwide in Argentina, and an incidence of 1.76 cases per 100,000 inhabitants per year. Considering the epidemiology of MS in Argentina, the total number of patients affected is estimated at 5,000-8,000 patients, with nearly 55%-65% of patients having a relapsing-remitting MS subtype of the disease. The aim of this review is to provide an overview of current and emerging treatments available in Argentina for patients with MS.
引用
收藏
页码：103 / 109
页数：7
相关论文
共 50 条
  • [31] Alemtuzumab: A Review in Relapsing Remitting Multiple Sclerosis
    Yahiya Y. Syed
    Drugs, 2021, 81 : 157 - 168
  • [32] Teriflunomide: A Review in Relapsing–Remitting Multiple Sclerosis
    Lesley J. Scott
    Drugs, 2019, 79 : 875 - 886
  • [33] Ozanimod: A Review in Relapsing Forms of Multiple Sclerosis
    Tina Nie
    Yahiya Y. Syed
    CNS Drugs, 2024, 38 (11) : 931 - 941
  • [34] Treatments for relapsing-remitting multiple sclerosis: summarising current information by network meta-analysis
    Del Santo, Fabiola
    Maratea, Dario
    Fadda, Valeria
    Trippoli, Sabrina
    Messori, Andrea
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 68 (04) : 441 - 448
  • [35] Decision making process in argentinian patients with multiple sclerosis
    Alonso, R.
    Chertcoff, A.
    Eizaguirre, M. B.
    Silva, B.
    Bauer, J.
    Curbelo, C.
    Cassara, F. Pagani
    Tkachuk, V.
    Imhoff, G.
    Leguizamon, F.
    Garcea, O.
    Carra, A.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 599 - 599
  • [36] Emerging oral drugs for relapsing-remitting multiple sclerosis
    Gasperini, Claudio
    Ruggieri, Serena
    EXPERT OPINION ON EMERGING DRUGS, 2011, 16 (04) : 697 - 712
  • [37] Pathogenesis of systemic sclerosis—current concept and emerging treatments
    Masutaka Furue
    Chikage Mitoma
    Hiroki Mitoma
    Gaku Tsuji
    Takahito Chiba
    Takeshi Nakahara
    Hiroshi Uchi
    Takafumi Kadono
    Immunologic Research, 2017, 65 : 790 - 797
  • [38] Current management of relapsing-remitting multiple sclerosis
    Sedal, L.
    Wilson, I. B.
    McDonald, E. A.
    INTERNAL MEDICINE JOURNAL, 2014, 44 (10) : 950 - 957
  • [39] Evaluation of the use of High Efficacy Treatments (HETs) in patients with relapsing remitting multiple sclerosis in Argentina
    Alonso, R.
    Casas, M.
    Lazaro, L.
    Pita, C.
    Cohen, L.
    Liguori, N. Fernandez
    Rojas, J. I.
    Pappolla, A.
    Patrucco, L.
    Cristiano, E.
    Burgos, M.
    Vrech, C.
    Piedrabuena, R.
    Lopez, P.
    Deri, N.
    Luetic, G.
    Miguez, J.
    Cabrera, M.
    Martinez, A.
    Zanga, G.
    Tkachuk, V.
    Tizio, S.
    Contentti, E. Carnero
    Knorre, E.
    Leguizamon, F.
    Mainella, C.
    Nofal, P.
    Liwacki, S.
    Hryb, J.
    Menichini, M.
    Pestchanker, C.
    Garcea, O.
    Silva, B.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 841 - 842
  • [40] Neuropsychological rehabilitation in patients with relapsing-remitting multiple sclerosis: a systematic review
    Redero, Daniel
    Lazaro, Esther
    Vazquez, Natalia
    Soria, Cristina
    APPLIED NEUROPSYCHOLOGY-ADULT, 2023,
12345